血管活性肠道产生的神经质瘤:难治性腹的罕见原因
Luiza Dornelles Penteado Pacheco E Silva1, Eliana M Monteiro Caran1
1Pediatric Oncology, Grupo de Apoio ao Adolescente e a Criança com Câncer (GRAACC) / Universidade Federal de São Paulo (UNIFESP), Sao Paulo, BRA.
Cureus
|September 27, 2024
概括
神经质瘤可以导致儿童慢性腹由于血管活性肠 (VIP) 生产. 这些儿科瘤的早期诊断和治疗显著提高了存活率.
科学领域:
- 儿科瘤学 儿科瘤学
- 胃肠病学 胃肠病学
- 内分泌学 在内分泌学.
背景情况:
- 神经质瘤是常见的儿童癌症.
- 一个子集通过血管活性肠 (VIP) 引起慢性腹.
- 隐性瘤的延迟诊断会影响治疗结果.
研究的目的:
- 确定患有神经细胞瘤和慢性腹的儿童的特征.
- 提醒医疗保健专业人员在耐火儿科腹中考虑神经质瘤.
- 改善这些罕见疾病的早期诊断和治疗.
主要方法:
- 神经质瘤病例的流行病学研究 (1975-2021年).
- 数据来源于MEDLINE,EMBASE和LILACS数据库中的数据.
- 对96个报告的病例进行描述性分析.
主要成果:
- 86.5%的患者在诊断之前出现了腹.
- 性神经母细胞瘤和腹部瘤是常见的亚型.
- 患有酸性疾病的患者经常出现低血清 (98%);观察到高VIP水平.
结论:
- 神经质瘤的血清VIP产生与更好的预后相关.
- 早期诊断和治疗对于改善生存和生活质量至关重要.
- 对于患有无法解释的慢性分泌性腹的儿童,建议对神经质瘤进行查.
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
152
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
152
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
178
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
178
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
153
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
153
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
186
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
186
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
222
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
222
Chronic Bowel Disorders: Introduction
408
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
408


